Showing 1 - 16 results of 16 for search 'Rafal Wojciechowski', query time: 0.06s
Refine Results
-
1
Guillelmus Durantis (1230/1237–1296) by Rafał Wojciechowski
Published 2025-02-01
Article -
2
-
3
WEB SERVER LATENCY REDUCTION STUDY by Fatma Mbarek, Volodymyr Mosorov, Rafał Wojciechowski
Published 2017-09-01
Article -
4
Optimal Digital Implementation of Fractional-Order Models in a Microcontroller by Mariusz Matusiak, Marcin Bąkała, Rafał Wojciechowski
Published 2020-03-01
Article -
5
WEB SERVER LATENCY REDUCTION STUDY by Fatma Mbarek, Volodymyr Mosorov, Rafał Wojciechowski
Published 2017-06-01
Article -
6
APLIKACJA MOBILNA WSPOMAGAJĄCA BADANIA ULTRASONOGRAFICZNE DOPPLERA by Michał Michalski, Marcin Bąkała, Rafał Wojciechowski
Published 2017-09-01
Article -
7
-
8
Application of the Salp Swarm Algorithm to Optimal Design of Tuned Inductive Choke by Łukasz Knypiński, Milena Kurzawa, Rafał Wojciechowski, Michał Gwóźdź
Published 2024-10-01
Article -
9
-
10
-
11
Osteoporosis in axial radiographic spondyloarthritis: diagnostic limitations of bone mineral density and the need for comprehensive fracture risk assessment by Paweł Żuchowski, Marta Dura, Daniel Jeka, Rafał Wojciechowski, Maciej Bierwagen, Michał Kułakowski
Published 2024-12-01
Article -
12
Assessment of the usefulness of skin autofluorescence as an indicator of disease activity and of the risk of developing diabetes in patients suffering from rheumatoid arthritis by Paweł Żuchowski, Katarzyna Kolossa, Sławomir Jeka, Rafał Wojciechowski, Arnika Wilińska-Jankowska, Marzena Waszczak
Published 2015-12-01
Article -
13
Comparative clinical efficacy and safety of the proposed biosimilar ABP 710 with infliximab reference product in patients with rheumatoid arthritis by Mark C. Genovese, Juan Sanchez-Burson, MyungShin Oh, Eva Balazs, Jeffrey Neal, Andrea Everding, Tomas Hala, Rafal Wojciechowski, Gary Fanjiang, Stanley Cohen
Published 2020-03-01
Article -
14
Efficacy and safety of biosimilar CT-P17 versus reference adalimumab in subjects with rheumatoid arthritis: 24-week results from a randomized study by Jonathan Kay, Janusz Jaworski, Rafal Wojciechowski, Piotr Wiland, Anna Dudek, Marek Krogulec, Slawomir Jeka, Agnieszka Zielinska, Jakub Trefler, Katarzyna Bartnicka-Maslowska, Magdalena Krajewska-Wlodarczyk, Piotr A. Klimiuk, Sang Joon Lee, Yun Ju Bae, Go Eun Yang, Jae Kyoung Yoo, Daniel E. Furst, Edward Keystone
Published 2021-02-01
Article -
15
Efficacy and safety of CT-P47 versus reference tocilizumab: 32-week results of a randomised, active-controlled, double-blind, phase III study in patients with rheumatoid arthritis,... by Edward Keystone, Josef S Smolen, Gerd R Burmester, Slawomir Jeka, Pawel Hrycaj, Janusz Jaworski, Anna Dudek, Artur Racewicz, Agnieszka Zielinska, YunJu Bae, Rafal Wojciechowski, Marek Krogulec, Jakub Trefler, Katarzyna Kolossa, Magdalena Krajewska-Włodarczyk, Piotr Adrian Klimiuk, SungHyun Kim, GoEun Yang, YooBin Jung, JiWoo Hong
Published 2024-10-01
Article -
16
LO-021 Interim safety and efficacy of subcutaneous (s.c.) dose ianalumab (VAY736; anti-BAFF-R mAb) administered monthly over 28 weeks in patients with systemic lupus erythematosus... by Yuko Kaneko, Masato Okada, Stephanie Finzel, Nan Shen, Elena Vishneva, Lingyun Sun, Bernadette Rojkovich, Alberta Hoi, Shin-Seok Lee, Piotr Leszczyński, Lie Dai, Rafal Wojciechowski, Cheng-Chung Wei, Katarzyna Romanowska-Prochnicka, Hiroshi Kaneko, Stanislav Ignatenko, Alexander Gordienko, Josefina Hernandez, Nancy Levin, Pongthorn Narongroeknawin, Hanna Ciferska, Masanari Kodera, Joung Liang Lan, Tunde Tarr, Yi Hsing Chen, Ajchara Koolvisoot, Eugeny Zotkin, Berta Paula magallares, Tirtha Sengupta, Carole Sips, Stephan Oliver
Published 2023-07-01Article